Skip to main content
. Author manuscript; available in PMC: 2008 Mar 20.
Published in final edited form as: J Proteome Res. 2006 Sep;5(9):2236–2240. doi: 10.1021/pr0504485

Figure 3.

Figure 3

A phyloproteomic analysis showing dichotomous distribution of cancers into two clades. A schematic cladogram of a comprehensive phyloproteomic analysis composed of 460 specimens representing ovarian, pancreatic, and prostate cancers as well as noncancerous specimens. Specimens of every cancer type are classified into two clades: a terminal and middle, as well as transitional clades. Healthy specimens are classified into a major healthy clade and transitional clades.